Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research focused on Ivacaftor and Cystic fibrosis, with related work in Mechanism of action, Exon, Action (physics). Notable publications include 'Clinical and functional efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis carrying the N1303K mutation', 'Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach for the W1282X nonsense mutation', and 'Molecular Mechanism of Action of Trimethylangelicin Derivatives as CFTR Modulators'.
Clinical and functional efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis carrying the N1303K mutation
Validating organoid-derived human intestinal monolayers for personalized therapy in cystic fibrosis
Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach for the W1282X nonsense mutation
Molecular Mechanism of Action of Trimethylangelicin Derivatives as CFTR Modulators